297 related articles for article (PubMed ID: 19095866)
1. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data.
Schug SA; Joshi GP; Camu F; Pan S; Cheung R
Anesth Analg; 2009 Jan; 108(1):299-307. PubMed ID: 19095866
[TBL] [Abstract][Full Text] [Related]
2. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.
Nussmeier NA; Whelton AA; Brown MT; Langford RM; Hoeft A; Parlow JL; Boyce SW; Verburg KM
N Engl J Med; 2005 Mar; 352(11):1081-91. PubMed ID: 15713945
[TBL] [Abstract][Full Text] [Related]
3. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects.
Gan TJ; Joshi GP; Zhao SZ; Hanna DB; Cheung RY; Chen C
Acta Anaesthesiol Scand; 2004 Oct; 48(9):1194-207. PubMed ID: 15352969
[TBL] [Abstract][Full Text] [Related]
4. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
Daniels SE; Desjardins PJ; Bird SR; Smugar SS; Tershakovec AM
Clin Ther; 2006 Jul; 28(7):1022-34. PubMed ID: 16990080
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery.
Nussmeier NA; Whelton AA; Brown MT; Joshi GP; Langford RM; Singla NK; Boye ME; Verburg KM
Anesthesiology; 2006 Mar; 104(3):518-26. PubMed ID: 16508400
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.
Ott E; Nussmeier NA; Duke PC; Feneck RO; Alston RP; Snabes MC; Hubbard RC; Hsu PH; Saidman LJ; Mangano DT; ;
J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1481-92. PubMed ID: 12830070
[TBL] [Abstract][Full Text] [Related]
7. Effect of parecoxib on postoperative pain after lumbar spine surgery: a bicenter, randomized, double-blinded, placebo-controlled trial.
Jirarattanaphochai K; Thienthong S; Sriraj W; Jung S; Pulnitiporn A; Lertsinudom S; Foocharoen T
Spine (Phila Pa 1976); 2008 Jan; 33(2):132-9. PubMed ID: 18197096
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
9. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty.
Viscusi ER; Gimbel JS; Halder AM; Snabes M; Brown MT; Verburg KM
Anesth Analg; 2008 Aug; 107(2):652-60. PubMed ID: 18633048
[TBL] [Abstract][Full Text] [Related]
10. Role of parecoxib in pre-emptive analgesia: comparison of the efficacy and safety of pre- and postoperative parecoxib in patients undergoing general surgery.
Bajaj P; Ballary CC; Dongre NA; Baliga VP; Desai AA
J Indian Med Assoc; 2004 May; 102(5):272, 274, 276-8. PubMed ID: 15636035
[TBL] [Abstract][Full Text] [Related]
11. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
Spalding WM; Reeves MJ; Whelton A
Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
Joshi GP; Gertler R; Fricker R
Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
[TBL] [Abstract][Full Text] [Related]
14. [The specific cox-2 inhibitor valdecoxib provides effective analgesia after inguinal hernia surgery].
Torres LM; Cabrera J; Martínez J; Calderón E; Fernández S; Chaves J
Rev Esp Anestesiol Reanim; 2004 Dec; 51(10):576-82. PubMed ID: 15641602
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis.
Aldington S; Shirtcliffe P; Weatherall M; Beasley R
N Z Med J; 2005 Nov; 118(1226):U1755. PubMed ID: 16311613
[TBL] [Abstract][Full Text] [Related]
16. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
[TBL] [Abstract][Full Text] [Related]
17. Multiple-day efficacy of parecoxib sodium treatment in postoperative bunionectomy pain.
Apfelbaum JL; Desjardins PJ; Brown MT; Verburg KM
Clin J Pain; 2008; 24(9):784-92. PubMed ID: 18936596
[TBL] [Abstract][Full Text] [Related]
18. Parecoxib, valdecoxib, and cardiovascular risk.
Furberg CD; Psaty BM; FitzGerald GA
Circulation; 2005 Jan; 111(3):249. PubMed ID: 15655125
[No Abstract] [Full Text] [Related]
19. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
Eisen GM; Goldstein JL; Hanna DB; Rublee DA
Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
